The combinatorial, multi-gene GeneSight test has been found to better predict antidepressant treatment outcomes for patients with depression, and their use of health care resources, than any of the ...
Myriad Genetics, Inc. MYGN recently published results from a meta-analysis in the Journal of Clinical Psychopharmacology, stating the superiority of the company’s GeneSight Psychotropic test over ...
The GeneSight test analyzes clinically important genetic variations in your DNA. The results of the test can inform your doctor about genes that may impact how you metabolize or respond to certain ...
SALT LAKE CITY, June 08, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today a newly published study in Psychiatry ...
YORK, Pa. — A simple cheek swab claims to give patients an individualized look at which medications are best suited for their mental health, based on their DNA. "There may be an issue where ...
On Monday, in its earnings release, Myriad Genetics Inc. (NASDAQ:MYGN) said Unitedhealth Group Inc’s (NYSE:UNH) UnitedHealthcare will stop covering multi-gene panel pharmacogenetic testing, including ...
SALT LAKE CITY, Sept. 3, 2025 – Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six ...
“For three years, it was like throwing darts at a dartboard – except, I was the dartboard,” said Ronni, whose acute suffering persisted as she and her health care providers searched for medication to ...
New study finds GeneSight CPGx precision medicine test provides significant health care cost savings
Mason, Ohio - August 12, 2015 - A new study published in Current Medical Research and Opinion demonstrated $1,036 in annual prescription savings per patient when healthcare providers used the ...
Women are nearly twice as likely to develop major depression than men. Causes of depression are often unknown, but several factors may increase a woman’s risk of depression. These factors include ...
Depression is a complicated condition, and so are the people it affects. It’s often difficult — and can take months or even years — to find the right drugs to treat the heterogeneous mood disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results